Creative Financial Designs’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Creative Financial Designs’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-40,805	Closed	-$93K	–	1741
2024 Q2	$93K	Buy	40,805 +300	+0.7%	+$1.15K	0.01%	595
2024 Q1	$175K	Buy	40,505 +5,225	+15%	+$18.2K	0.02%	449
2023 Q4	$108K	Buy	35,280 +17,475	+98%	+$32.8K	0.01%	525
2023 Q3	$25.6K	Buy	17,805 +300	+2%	+$581	﹤0.01%	796
2023 Q2	$43.6K	Buy	17,505 +6,605	+61%	+$18K	0.01%	665
2023 Q1	$29.2K	Sell	10,900 -1,100	-9%	-$5.29K	﹤0.01%	713
2022 Q4	$65.2K	Hold	12,000	–	–	0.01%	522
2022 Q3	$150K	Buy	+12,000	New	+$137K	0.02%	351

Creative Financial Designs's GTHX Position: Q3 2024 in Review

Creative Financial Designs sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q3 2024, closing a stake of 40,805 shares — an estimated $93K sold.

Creative Financial Designs first reported a position in GTHX in Q3 2022 and held it in 8 quarters. The position peaked at $175K in Q1 2024. 0 funds tracked by Wall St. Rank hold GTHX as of Q3 2024.

Creative Financial Designs reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Creative Financial Designs sold 40,805 G1 Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $93K.
Creative Financial Designs first reported a position in G1 Therapeutics, Inc. Common Stock in Q3 2022 and held it in 8 quarters.
Creative Financial Designs's G1 Therapeutics, Inc. Common Stock position peaked at $175K in Q1 2024.
0 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Creative Financial Designs's 13F filing for Q3 2024, filed 28 Oct 2024.